Peer-reviewed 2-year follow up clinical data published in 2023 on ZetaMet™ (Zeta-BC-003) demonstrated resolution of 7 lytic lesions (radiated and non-radiated), reduction in pain, significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback